U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Release of ORA Laboratory Analytical Results to the Responsible Party
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Release of ORA Laboratory Analytical Results to the Responsible Party Guidance for Food and Drug Administration Staff March 2019

Final
Docket Number:
FDA-2019-D-1163
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Human Foods Program
Office of Inspections and Investigations
Center for Devices and Radiological Health
Center for Tobacco Products

This document provides guidance for FDA staff regarding the release of final and, in some circumstances, preliminary Office of Regulatory Affairs (ORA) laboratory analytical results to the responsible party. This policy applies to samples collected during FDA regulatory activities and analyzed in ORA laboratories.  It applies to FDA personnel assigned to deliver and discuss ORA laboratory analytical results with the responsible party. The policy does not require the responsible party to file a Freedom of Information Act (FOIA) request for the records.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2019-D-1163.

Back to Top